FDA Inspection 1256132 - Amgen, Inc. - March 13, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Amgen, Inc., with an inspection on March 13, 2025, issued by the Los Angeles District Office, covering human drugs.

Company: Amgen, Inc.
Inspection Date: March 13, 2025
Product Type: Human Drugs
Office: Los Angeles District Office

Open in Dashboard

ID · 8601b5a4-a27d-4f90-9399-1e0398db8be7

Violation Codes4

21 CFR 211.113(b)21 CFR 211.160(b)(2)21 CFR 211.192FDCA 582(b)(4)

Full citation text and observation details available on the Dashboard.